Referral to endocrinology is appropriate for complex cases, inadequate response, or significant adverse effects
Its approved by the MHRA, although only officially for type 2 diabetes
The GLP-1 Baby Phenomenon: Understanding Unexpected Pregnancies Prompt: Social media feed mockup on a phone with posts tagged #GLP1Baby, in front of a surprised but happy couple holding a positive pregnancy test, gentle humor but respectful
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
An update on the safety of SGLT2 inhibitors